Dsip
The short answer. More people than not who report on Dsip say it helped (59% of 57). It is most often used for sleep: 72% of 65 reports say that improved. There is a moderate body of research — 0 meta-analyses and 5 trials. The most common complaint is vivid dreams. It is not an approved supplement and carries real risks.
From 111 mentions in total — the rest didn't say how it went and aren't counted.
What Dsip does, according to users
Of the people who reported each effect, the share who said it got better.
4 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found. 0 meta-analyses on PubMed ↗ · 5 randomized trials ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“If you are brave enough for subcutaneous injections get some DSIP. Best sleep i ever had.”
“I tried Delta Sleep-Inducing Peptide (DSIP) last night and it improved by Deep and REM sleep by about 40mins each!!”
“After a few nights of the DSIP I couldn't believe it. I woke up feeling like I actually rested, the inflammation in my joints was noticeably better, my overall mood and outlook was better.”
“DSIP - the first morning after I felt like a different person. All the stress and anxiety from the day before is a distant memory.”
Dsip compared
Other options for sleep
Sources
- User reports: 111 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate